
© 2024 aktien.guide
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
20:34 | CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo | ||
Mo | Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers | ||
Mo | Halozyme: Bristol Myers Squibb Secures CHMP's Positive Opinion For New Cancer Drug Delivery Method | NEW YORK CITY (dpa-AFX) - Halozyme Therapeutics, Inc. (HALO), Monday announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products for Human... ► Artikel lesen | |
Mo | BMO maintains Bristol-Myers $61 target, Market Perform rating | ||
Sa | Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday? |